2 studies found for:    Open Studies | "Severe Acute Respiratory Syndrome"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Unknown  A Multi-centre, Double-blinded, Randomized, Placebo-controlled Trial on the Efficacy and Safety of Lopinavir / Ritonavir Plus Ribavirin in the Treatment of Severe Acute Respiratory Syndrome
Condition: Severe Acute Respiratory Syndrome
Intervention: Drug: Lopinavir / Ritonavir plus Ribavirin
2 Not yet recruiting Seroprevalence of MERS-CoV IgG in Healthcare Workers
Condition: Coronavirus Infections
Intervention:

Indicates status has not been verified in more than two years